Literature DB >> 20428911

Evaluation of Legionella V-TesT for the detection of Legionella pneumophila antigen in urine samples.

J P Bruin1, M F Peeters, E P F Ijzerman, B M W Diederen.   

Abstract

We evaluated a new immunochromatographic assay (Legionella V-TesT, Coris BioConcept, Gembloux, Belgium) for its ability to detect Legionella pneumophila serogroup 1 antigen in urine. Test devices were read at various time points to determine the optimum incubation time regarding performance. The results were compared with those obtained with the BinaxNOW urinary antigen test. The sensitivity and specificity were 82.2% and 98.6%, respectively, for the Legionella V-TesT and 83.9% and 100%, respectively, for the BinaxNOW urinary antigen test after 15 min of incubation. When tests were examined after 60 min, the sensitivity for both tests increased to 91.5%.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20428911     DOI: 10.1007/s10096-010-0932-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  Comparison of diagnostic sensitivities of three assays (Bartels enzyme immunoassay [EIA], Biotest EIA, and Binax NOW immunochromatographic test) for detection of Legionella pneumophila serogroup 1 antigen in urine.

Authors:  Carmen Guerrero; Carmen M Toldos; Genoveva Yagüe; Cristobal Ramírez; Tomás Rodríguez; Manuel Segovia
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Diagnosis of Legionella infection.

Authors:  David R Murdoch
Journal:  Clin Infect Dis       Date:  2002-12-12       Impact factor: 9.079

Review 3.  Diagnosis of Legionella infection in Legionnaires' disease.

Authors:  J W Den Boer; E P F Yzerman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

4.  Evaluation of two new immunochromatographic assays (Rapid U Legionella antigen test and SD Bioline Legionella antigen test) for detection of Legionella pneumophila serogroup 1 antigen in urine.

Authors:  Bram M W Diederen; Marcel F Peeters
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  Delay in appropriate therapy of Legionella pneumonia associated with increased mortality.

Authors:  C H Heath; D I Grove; D F Looke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

6.  Evaluation of the SAS Legionella Test, a new immunochromatographic assay for the detection of Legionella pneumophila serogroup 1 antigen in urine.

Authors:  B M W Diederen; M F Peeters
Journal:  Clin Microbiol Infect       Date:  2007-01       Impact factor: 8.067

7.  Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; H M Jansen; W G Boersma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

Review 8.  Legionella spp. and Legionnaires' disease.

Authors:  B M W Diederen
Journal:  J Infect       Date:  2007-11-05       Impact factor: 6.072

Review 9.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 10.  Legionnaires' disease: clinical, epidemiological, and public health perspectives.

Authors:  R F Breiman; J C Butler
Journal:  Semin Respir Infect       Date:  1998-06
  10 in total
  2 in total

1.  Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers.

Authors:  L Beraud; K Gervasoni; A M Freydiere; G Descours; A G Ranc; F Vandenesch; G Lina; V Gaia; S Jarraud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-20       Impact factor: 3.267

2.  Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens.

Authors:  Anne-Claire Andries; Veasna Duong; Sivuth Ong; Sopheaktra Ros; Anavaj Sakuntabhai; Paul Horwood; Philippe Dussart; Philippe Buchy
Journal:  BMC Infect Dis       Date:  2016-05-16       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.